KZR - Kezar Life Sciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
0
0
0
0
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
24,605
18,136
6,469
7,373
Selling General and Administrative
9,166
6,590
2,280
1,617
Total Operating Expenses
33,771
24,726
8,749
8,990
Operating Income or Loss
-33,771
-24,726
-8,749
-8,990
Interest Expense
-
-
-
-
Total Other Income/Expenses Net
-
-
-
-
Income Before Tax
-31,290
-23,167
-8,517
-8,990
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-31,290
-23,167
-8,517
-8,990
Net Income
-31,290
-23,167
-8,517
-8,990
Net Income available to common shareholders
-31,290
-23,167
-8,517
-8,990
Reported EPS
Basic
-
-2.26
-0.87
-0.69
Diluted
-
-2.26
-0.87
-0.69
Weighted average shares outstanding
Basic
-
10,265
9,763
13,021
Diluted
-
10,265
9,763
13,021
EBITDA
-
-24,036
-8,574
-8,836